BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29736797)

  • 1. β-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma).
    Suzuki Y; Ichihara S; Kawasaki T; Yanai H; Kitagawa S; Shimoyama Y; Nakamura S; Nakaguro M
    Virchows Arch; 2018 Aug; 473(2):235-239. PubMed ID: 29736797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear expression and gain-of-function β-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker.
    Lasota J; Felisiak-Golabek A; Aly FZ; Wang ZF; Thompson LD; Miettinen M
    Mod Pathol; 2015 May; 28(5):715-20. PubMed ID: 25431235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent mutations within the amino-terminal region of β-catenin are probable key molecular driver events in sinonasal hemangiopericytoma.
    Haller F; Bieg M; Moskalev EA; Barthelmeß S; Geddert H; Boltze C; Diessl N; Braumandl K; Brors B; Iro H; Hartmann A; Wiemann S; Agaimy A
    Am J Pathol; 2015 Feb; 185(2):563-71. PubMed ID: 25482924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.
    Ruz-Caracuel I; López-Janeiro Á; Heredia-Soto V; Ramón-Patino JL; Yébenes L; Berjón A; Hernández A; Gallego A; Ruiz P; Redondo A; Peláez-García A; Mendiola M; Hardisson D
    Virchows Arch; 2021 Dec; 479(6):1167-1176. PubMed ID: 34420090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomangiopericytoma of the Nasal Cavity with CTNNB1 p.S37C Mutation: A Case Report and Literature Review.
    Kono M; Bandoh N; Matsuoka R; Goto T; Akahane T; Kato Y; Nakano H; Yamaguchi T; Harabuchi Y; Nishihara H
    Head Neck Pathol; 2019 Sep; 13(3):298-303. PubMed ID: 30206803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinonasal glomangiopericytoma: A clinicopathologic study.
    Obeidin F; Jennings LJ; Alexiev BA
    Pathol Res Pract; 2019 May; 215(5):983-987. PubMed ID: 30739805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
    Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
    Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
    Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear β-Catenin Expression is Frequent in Sinonasal Hemangiopericytoma and Its Mimics.
    Jo VY; Fletcher CDM
    Head Neck Pathol; 2017 Jun; 11(2):119-123. PubMed ID: 27325236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
    Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
    Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations.
    Irving JA; Lee CH; Yip S; Oliva E; McCluggage WG; Young RH
    Am J Surg Pathol; 2015 Oct; 39(10):1420-6. PubMed ID: 26200099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Glomangiopericytoma at the Nasal Septum.
    Anzai T; Saito T; Tsuyama S; Toh M; Ikeda K; Ito S
    Head Neck Pathol; 2018 Dec; 12(4):572-575. PubMed ID: 29168109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomangiopericytoma and glomus tumor of the sinonasal tract: A report of two cases with emphasis on the differential diagnosis.
    Kim J; Jeon J; Kim DH; Park ES; Maeng LS; Jun SY
    Pathol Int; 2016 Jun; 66(6):348-50. PubMed ID: 26972077
    [No Abstract]   [Full Text] [Related]  

  • 14. Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study.
    Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Wada J; Urabe S; Hirano T; Kawano K; Suzuki M; Yokoyama S; Daa T
    Diagn Pathol; 2018 Jul; 13(1):48. PubMed ID: 30053869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
    Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
    Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypical and molecular distinctness of sinonasal haemangiopericytoma compared to solitary fibrous tumour of the sinonasal tract.
    Agaimy A; Barthelmeß S; Geddert H; Boltze C; Moskalev EA; Koch M; Wiemann S; Hartmann A; Haller F
    Histopathology; 2014 Nov; 65(5):667-73. PubMed ID: 24807787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34-Positive Spindle Cell Tumor With
    Iwamura R; Nawata A; Akaike R; Kitamura T; Hisaoka M
    Int J Surg Pathol; 2024 Apr; 32(2):408-413. PubMed ID: 37287277
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Hong CS; Khan M; Sukys JM; Prasad M; Erson-Omay EZ; Vining EM; Omay SB
    Cold Spring Harb Mol Case Stud; 2022 Jan; 8(1):. PubMed ID: 34667073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
    Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
    Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
    Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.